Prophylactic Properties of Carrot Juice in Patients With High-Risk Colorectal Polyps

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorOdense University Hospital

About this trial

The goal of this prospective randomized double-blinded bi-national study is to test the prophylactic effect of polyacetylenes from carrots on the population of patients who had a resection of high-risk adenomas of the large bowel.

The main question it aims to answer is: Will carrot juice rich in polyacetylenes inhibit neoplastic transformation and growth in high-risk humans?

Participants will have to drink 100 ml of juice daily after the adenoma resection for 1 year and keep a simple diary/calendar.

Researchers will compare the group with ingestion of Falcarinol (FaOH) / Falcarindiol (FaDOH) rich carrot juice versus the group consuming placebo juice, to see if the polyacetylenes significantly reduces neoplastic transformation and growth in high-risk patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Any type of resection for adenomas larger than 20 mm in size (endoscopically evaluated) or endoscopically resected T1 cancers.

Acceptance of the treatment and follow-up program.

Capability to understand and follow the instructions.

Disqualifiers

Patients allocated to "high-risk" group because of many small polyps (>4).

Pregnancy.

Known relevant allergies.

Chronic consumption of COX (cyclooxygenase) inhibitors (Aspirin, Celecoxib, Ibuprofen, Diclofenac, Ketoprofen, Ketorolac, Indometacin, Naproxen, Piroxicam) or immunosuppressive agents (Methotrexate, Azathioprine or glucocorticoids).

Trial design

Design model

Parallel

Treatments tested in this trial

  • Carrot juice from Yellowstone carrots cultivars

    Dietary supplement

    Consumption of 100 ml of carrot juice daily for 1 year

  • Placebo juice

    Dietary supplement

    Consumption of 100 ml of placebo juice daily for 1 year

Treatment groups

400 Participants
are divided into 2 treatment groups
Group A: Carrot juiceActive comparator 1 intervention
Group B: Placebo juicePlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Number and size of recurrent polyps found at the one-year follow up colonoscopy

The combined endpoint (number x size of recurrent polyps) after 1 year of treatment.

Time frame
1 year

Secondary outcomes

1

Polyp number and mean size per patient and the relation with the carrot consumption measurement

A covariate analysis of carrot consumption (concentration of polyacetylenes exposure) measured through diaries, calendar and questionnaires and the findings at the 1 year colonoscopy (number of polyps multiplied by mean diameter of adenomas per patient).

Time frame
1 year
2

Compliance rate (Juice consumption level) and side effects

Assessment of compliance rate and side effects through diary, calendar marks and questionnaire

Time frame
1 year
3

The number of polyps with low, medium, high degree of dysplasia and cancer

Assessment of polyps through endoscopy and pathology reports

Time frame
1 year
4

Acceptability of treatment

Assessment of acceptance and ways to improve carrot products through diary and questionnaire

Time frame
1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Odense University Hospital

Lead sponsor

Karolinska Institutet

Collaborator

Umeå University

Collaborator

Uppsala University Hospital

Collaborator

Svendborg Hospital

Collaborator

Ersta Hospital, Sweden

Collaborator

St Goran's Hospital

Collaborator

Sahlgrenska University Hospital

Collaborator